The transverse retractors segment by product is estimated to lead the market growth during the forecast period.

According to a new market research study of “North America Cervical Retractors Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, End User and Country.” The North America cervical retractors market is expected to reach US$ 127.12 million by 2028 from US$ 71.15 million in 2020; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028. The report highlights trends prevailing in the North America cervical retractors market and the factors driving market along with those that act as hindrances.

The North America cervical retractors market, by product, is segmented into transverse retractors, and longitudinal retractors. In 2020, the transverse retractors segment held the largest share of the market, by product. And the same segment is estimated to grow at significant CAGR during the forecast period due to growing numbers of endoscopy procedures, increasing product developments, and product launches.

Surge in aging population is poised to one of the most significant causes of social transformations in the 21st century. As per the data published by the United Nations, the world had ~962 million people with age 60 or above in 2017, which was 13% of the global population in that year. Further, this population is estimated to grow at a rate of 3% every year. Spinal conditions are the most common conditions observed in older adults, affecting 5–55% of people with age 55 and above. These medical conditions are associated with a high risk for adverse outcomes such as mortality, disability, institutionalization, and hospitalization. Hence, with the growing geriatric population and rise in prevalence of associated cervical pain, the cervical retractors market is witnessing significant growth. Different studies suggest that many adults show no symptoms of degenerative disc disease, even though a high percentage of them still experience the signs of disc degeneration on the spine, in on an MRI. According to one of the studies, ~50% of people start showing some signs of disc degeneration in an MRI by their early 20s. While nearly everyone eventually gets cervical degenerative disc disease with age, and factors such as genetics, obesity, and smoking accelerate the process of developing this disease, so that the people become symptomatic sooner. Hence such rising incidences in cervical disc degeneration and higher number of cervical spine surgeries across globe also boosts the market growth.

The North American region is highly affected due to the outbreak of the COVID-19 pandemic. In the US, due to an increasing number of infected patients, healthcare professionals and leading organizations are distracting the flow of healthcare resources from research & development to primary care, which is slowing down the process of innovation. Over the past couple of years, the treatment processes for the COVID-19 have been developed. Thus, there have been remarkable reductions of the load over the healthcare system and other healthcare services such as treatments, surgeries, and others. Moreover, the vaccination process has gained speed, and more and more people are getting their vaccinations. Thus, the COVID-19 has a relatively better impact on the cervical retractors market.

The North America cervical retractors market, by product, is segmented into transverse retractors, and longitudinal retractors. Based on end user, the North America cervical retractors market is segmented into hospital, clinic, and others. Geographically, the North America cervical retractors market is segmented into the US, Canada, and Mexico.

Aesculap Implant Systems, LLC, TeDan Surgical Innovations, NSI Health Systems, Thompson Surgical, Novo Surgical, Inc, Life Spine, Globus Medical, Inc.and Rudolf Storz GmbH are among the leading companies operating in the North America cervical retractors market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com